Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
about
Perioperative prebiotics, probiotics or synbiotics for elective abdominal surgery in adultsSepsis in Canadian children: a national analysis using administrative data.Designing a pediatric severe sepsis screening tool.Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis.Sepsis bundles and compliance with clinical guidelines.Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing.Effects of increasing compliance with minimal sedation on duration of mechanical ventilation: a quality improvement intervention.Simplified pharmacoeconomics of critical care and severe sepsis.Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.A microcosting study of intensive care unit stay in the Netherlands.Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury.Molecular diagnosis of sepsis: New aspects and recent developments.Evaluation of the Association of Early Elevated Lactate With Outcomes in Children With Severe Sepsis or Septic Shock.Prehospital Sepsis Project (PSP): knowledge and attitudes of United States advanced out-of-hospital care providers.Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice.Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study.Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock.[Cross sectional study of structural quality of German intensive care units. A reevaluation of the DIVI register].Factors associated with non-response at health-related quality of life follow-up in a septic shock trial.Identification of Sepsis among Ward Patients.Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.New Technologies in Clinical Microbiology.
P2860
Q24236166-6B0EB447-8EA0-4899-B326-A132287E0C13Q30881137-206AA867-6F31-4CBE-AE9D-E7C55CE56C1FQ33759988-B57DA7B5-8F48-4A3B-9F0A-0FFB9C4D7838Q34448058-A2B1EE90-50E7-4C77-AB40-366FBE06351AQ34630203-365EE08A-A5F4-424D-92B1-45C22345C69EQ36118861-8EDF368F-F20D-4782-B45A-1EFDE1107DA0Q36633547-C5F3F974-DF71-44A9-965B-E7A1E36197CBQ36951502-01912400-70AB-4BFD-935D-8FA84845F5E0Q36990515-6C3E6D11-6029-47E3-A02B-BECD2C4ACDA5Q37175896-CDBB87B9-9A75-4422-8844-391A1F963856Q37210150-C243493D-119A-451F-9983-A7B82C9A3766Q38286512-2F05B768-BE6A-41BD-B9F8-9B9A252379D2Q39029218-EA856816-D12C-4D1A-9DB2-233E87F73795Q40081568-4BC3E679-2C13-4EBA-836C-446A0DB38FE8Q42016440-746FF33D-45C6-4D91-B0A8-BBA6C3AC78F0Q42217659-0806EA47-523D-4324-B332-7808A15413AEQ44658786-8575AF6B-73A3-4FF8-915D-2E23FE6A7AFCQ45198850-76A650F6-16E4-4235-8045-267BB74C9016Q47568917-6169123C-C52C-4EB9-9FC6-D32C7E4FE16FQ48119444-5DD27A27-0B91-485A-BCC4-2A5A2F3AC588Q55043783-41B26A83-C469-481E-8F3F-91671BC71677Q55400297-2FE5A357-2499-438A-9906-DF78A679A443
P2860
Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Economic aspects of severe sep ...... cost effectiveness of therapy.
@ast
Economic aspects of severe sep ...... cost effectiveness of therapy.
@en
type
label
Economic aspects of severe sep ...... cost effectiveness of therapy.
@ast
Economic aspects of severe sep ...... cost effectiveness of therapy.
@en
prefLabel
Economic aspects of severe sep ...... cost effectiveness of therapy.
@ast
Economic aspects of severe sep ...... cost effectiveness of therapy.
@en
P1433
P1476
Economic aspects of severe sep ...... cost effectiveness of therapy.
@en
P2093
Heinz Schneider
Hilmar Burchardi
P304
P356
10.2165/00019053-200422120-00003
P577
2004-01-01T00:00:00Z
P5875
P6179
1009292170